Cargando…
The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection causes coronavirus disease-19 (COVID-19), which is characterized by clinical manifestations such as pneumonia, lymphopenia, severe acute respiratory distress, and cytokine storm. S glycoprotein of SARS-CoV-2 binds to angiotensin-...
Autores principales: | Beeraka, Narasimha M., Tulimilli, SubbaRao V., Karnik, Medha, Sadhu, Surya P., Pragada, Rajeswara Rao, Aliev, Gjumrakch, Madhunapantula, SubbaRao V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168478/ https://www.ncbi.nlm.nih.gov/pubmed/34159203 http://dx.doi.org/10.1155/2021/8160860 |
Ejemplares similares
-
The Role of Exosomes in Stemness and Neurodegenerative Diseases—Chemoresistant-Cancer Therapeutics and Phytochemicals
por: Beeraka, Narasimha M., et al.
Publicado: (2020) -
Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status
por: Beeraka, Narasimha M., et al.
Publicado: (2020) -
A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development
por: Karnik, Medha, et al.
Publicado: (2021) -
Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
por: Tulimilli, SubbaRao V., et al.
Publicado: (2022) -
COVID-19: Diabetes Perspective—Pathophysiology and Management
por: Dallavalasa, Siva, et al.
Publicado: (2023)